Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Theophylline as a bronchodilator in COPD and its combination with inhaled beta-adrenergic drugs Jenne JWChest 1987[Jul]; 92 (1 Suppl): 7S-14SThe bronchodilating action of theophylline in COPD has been examined, with emphasis on its combined use with inhaled beta 2 agonists. The suggestion is made that failure to recognize the nonlinearity of the dose-response curves for bronchodilators has resulted in underestimating their combined action. Recent studies suggest that systemic theophylline has somewhat different actions on the airways in COPD than inhaled beta agonists, and that more bronchodilation may be possible when the two are used together than large doses of either one. By analogy, with asthma the suggestion is also made that the addition of theophylline is also likely to provide a more constant bronchodilation, reducing peak-trough variations in flow. The most complete clinical comparison to date suggests that, in currently sanctioned doses, a regimen containing both theophylline and an inhaled beta 2 agonist provides significantly greater bronchodilation than either drug alone, with fewer patient withdrawals. Further carefully designed studies are needed to resolve this issue, and particularly, to identify those patients who will derive the greatest benefit from a combined regimen.|Adrenergic beta-Agonists/*administration & dosage/pharmacology[MESH]|Albuterol/administration & dosage[MESH]|Animals[MESH]|Asthma/drug therapy[MESH]|Bronchi/drug effects[MESH]|Bronchitis/drug therapy[MESH]|Clinical Trials as Topic[MESH]|Culture Techniques[MESH]|Dogs[MESH]|Dose-Response Relationship, Drug[MESH]|Drug Therapy, Combination[MESH]|Forced Expiratory Volume[MESH]|Humans[MESH]|Isoproterenol/administration & dosage[MESH]|Lung Diseases, Obstructive/*drug therapy/physiopathology[MESH]|Lung/physiopathology[MESH]|Respiratory Therapy[MESH]|Theophylline/*administration & dosage/pharmacology[MESH]|Work of Breathing/drug effects[MESH] |